A Clinical Study Evaluaing the Efficacy, Safety, and Patient Satisfaction of Injectable Hylaronic Acid With 0.3% Lidocain Hydrochloride, Prevelle Silk, for Superficial, Vertical Perioral Lines and Superficial, Horizontal, Lateral Canthal Lines
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01267149|
Recruitment Status : Unknown
Verified December 2010 by Goldman, Butterwick, Fitzpatrick and Groff.
Recruitment status was: Recruiting
First Posted : December 28, 2010
Last Update Posted : December 28, 2010
Statistical Hypotheses The Null Hypothesis: There is no difference in the reduction of lines in the treated areas as compared to baseline.
Alternative Hypothesis: There is a difference in the reduction of lines in the treated areas as compared to baseline.
|Condition or disease|
|Study Type :||Observational|
|Estimated Enrollment :||13 participants|
|Official Title:||Phase 4 Study - A Clinical Study Evaluaing the Efficacy, Safety, and Patient Satisfaction of Injectable Hylaronic Acid With 0.3% Lidocain Hydrochloride, Prevelle Silk, for Superficial, Vertical Perioral Lines and Superficial, Horizontal, Lateral Canthal Lines|
|Study Start Date :||August 2010|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01267149
|Contact: Karina Brazdys, RN||858-657-1002 ext email@example.com|
|Contact: Donna Perez||858-657-1002 ext firstname.lastname@example.org|
|United States, California|
|Goldman, Butterwick, Fitzpatrick and Groff||Recruiting|
|La Jolla, California, United States, 92121|
|Contact: Karina Brazdys, RN 858-657-1002 ext 109 email@example.com|
|Contact: Donna Perez 858-657-1002 ext 120 firstname.lastname@example.org|
|Principal Investigator: Mitchell P. Goldman, MD|
|The Maas Clinic||Recruiting|
|San Francisco, California, United States, 94115|
|Contact: Emily Shamban 415-567-7000 email@example.com|
|Principal Investigator: Corey Mass, MD|
|Principal Investigator:||Mitchell P Goldman, MD||Dermatology and Cosmetic Laser Associated La Jolla|